Conditionally replicative adenoviral vectors for cancer gene therapy

Jesús Gómez-Navarro, David T. Curiel

Research output: Contribution to journalReview articlepeer-review

35 Scopus citations

Abstract

During the past century, many attempts have been made to exploit the ability of some viruses to infect and destroy cancer cells. Crippled, non-replicative viruses have been used as vectors to transfer genes into tumours. Both strategies have serious limitations. The time is now ripe, however, for full convergence of these two research tracks. On the one hand, the intratumoral propagation of replicative viruses would overcome the low levels of gene transfer achieved by current viral vectors. On the other hand, the versatility provided by vectors encoding foreign genes, which are limited in their uses only by our ingenuity, would overcome the physiological barriers to robust propagation of the viral progeny in the tumour. This empowering synthesis will provide truly new opportunities that might realise the promises of gene transfer for the therapy of cancer.

Original languageEnglish
Pages (from-to)148-158
Number of pages11
JournalLancet Oncology
Volume1
Issue number3
DOIs
StatePublished - Nov 1 2000
Externally publishedYes

Fingerprint Dive into the research topics of 'Conditionally replicative adenoviral vectors for cancer gene therapy'. Together they form a unique fingerprint.

Cite this